Treatment of type 2 diabetes with rosiglitazone associated with increased risk of cardiovascular events among older adults

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2008年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [1] Is rosiglitazone associated with increased risk for cardiovascular events?
    Hanefeld, M.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (12): : 648 - 649
  • [2] Is rosiglitazone associated with increased risk for cardiovascular events?
    Markolf Hanefeld
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 648 - 649
  • [3] Increased risk of cardiovascular events among type 2 diabetes patients with dyslipidemia
    Blonde, Lawrence
    Fox, Kathleen M.
    Ohsfeldt, Robert L.
    Parikh, Shamik
    Grandy, Susan
    CIRCULATION, 2007, 115 (08) : E230 - E230
  • [4] Insomnia symptoms are associated with an increased risk of type 2 diabetes mellitus among adults aged 50 and older
    Yao, Wenqin
    Luo, Jia
    Yu, Xiaohui
    Jiang, Wenjie
    Zhang, Dongfeng
    SLEEP AND BREATHING, 2022, 26 (03) : 1409 - 1416
  • [5] Insomnia symptoms are associated with an increased risk of type 2 diabetes mellitus among adults aged 50 and older
    Wenqin Yao
    Jia Luo
    Xiaohui Yu
    Wenjie Jiang
    Dongfeng Zhang
    Sleep and Breathing, 2022, 26 : 1409 - 1416
  • [6] Hypoglycemic Events May Be Associated with an Increased Risk of Acute Cardiovascular Events in Patients with Type 2 Diabetes
    Johnston, Stephen S.
    Conner, Christopher
    Aagren, Mark
    Smith, David M.
    Bouchard, Jonathan
    DIABETES, 2010, 59 : A8 - A8
  • [7] Increased risk of cardiovascular events as a result of delay in treatment intensification for patients with Type 2 diabetes
    Khunti, K.
    Paul, S.
    Thorsted, B. L.
    Wolden, M. L.
    Klein, K.
    DIABETIC MEDICINE, 2015, 32 : 116 - 116
  • [8] Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
    Schwartz, Ann V.
    Garnero, Patrick
    Hillier, Teresa A.
    Sellmeyer, Deborah E.
    Strotmeyer, Elsa S.
    Feingold, Kenneth R.
    Resnick, Helaine E.
    Tylavsky, Frances A.
    Black, Dennis M.
    Cummings, Steven R.
    Harris, Tamara B.
    Bauer, Douglas C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07): : 2380 - 2386
  • [9] High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events
    Stoekenbroek, R. M.
    Rensing, K. L.
    Moens, S. J. Bernelot
    Nieuwdorp, M.
    DeVries, J. H.
    Zwinderman, A. H.
    Stroes, E. S.
    Currie, C. J.
    Hutten, B. A.
    ATHEROSCLEROSIS, 2015, 240 (02) : 318 - 323
  • [10] Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
    Hertzel C Gerstein
    Salim Yusuf
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 798 - 799
12345